Medical News

RSS

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

St. Jude Medical, Inc., a global medical device company, today announced regulatory and reimbursement approval from the Australian Therapeutic Goods Administration of its Brio™ deep brain stimulation system for treating the symptoms of Parkinson’s disease.

23 Mar 2010

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.

23 Mar 2010

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

Oncothyreon Inc. today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., have temporarily suspended the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine). The suspension is the result of a suspected unexpected serious adverse reaction in a patient with multiple myeloma participating in an exploratory clinical trial.

23 Mar 2010

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today it has received U.S. Food and Drug Administration (FDA) approval for NBM-200MP, a non-invasive oximetry and low signal oximetry sensor.

23 Mar 2010

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.

23 Mar 2010

Texas jury returns binding verdict of invalidity on two Covidien's patent claims covering trocar seal technology

Applied Medical announced today that a United States District Court jury for the Eastern District of Texas returned a binding verdict of invalidity of two claims of a Covidien patent covering trocar seal technology.

23 Mar 2010

ReGear Life Sciences achieves preferred partner status with Genesis Rehab Services

ReGear Life Sciences, Inc. announces that it has been named a Preferred Partner to Genesis Rehab Services.

23 Mar 2010

NMA to discuss impact of historic health care reform legislation on health disparities

With the passage of the historic health care legislation, the National Medical Association (NMA), the nation's oldest and largest organization representing the interests of 30,000 African American physicians will hold a press conference to address health care reform implementation and its impact on health disparities.

23 Mar 2010

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Mach One Corporation, a global wellness solutions company, today announced the completion of a “Definitive Agreement” for the terms and conditions for the merger and acquisition of White Hat Brands, LLC, producers of a variety of all natural, multi-vitamin-fortified juice beverages for children under the brand name Dog On It!™.

23 Mar 2010

Visual collaboration makes its way into healthcare services

Evolving patients' needs, limited number of medical specialists in remote areas, and technological advances are some of the most important factors driving interest in visual collaboration in healthcare.

23 Mar 2010

EMA validates InterMune's pirfenidone MAA for IPF

InterMune, Inc. today announced that the company's Marketing Authorization Application (MAA), submitted on March 2 seeking approval of pirfenidone for the treatment of idiopathic pulmonary fibrosis (IPF) in adults, was validated by the European Medicines Agency (EMA). Validation of the MAA by the EMA indicates that the application is complete and that the review process will begin on March 24. The proposed trade name for pirfenidone in both the United States and Europe is Esbriet®.

23 Mar 2010

Breathing diesel exhaust during pregnancy linked with sluggishness in offspring

Breathing diesel exhaust during pregnancy is associated with sluggishness in offspring. Researchers writing in BioMed Central's open access journal Particle and Fibre Toxicology studied the effects of pollution exposure in mice, finding that the offspring of mothers who breathed diesel fumes while pregnant were less likely to show spontaneous movement.

23 Mar 2010

Alnylam Pharmaceuticals earns $20M technology transfer payment from Takeda Pharmaceutical

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced that it has earned a $20 million technology transfer payment from Takeda Pharmaceutical Company Limited as part of the strategic alliance the companies formed in May 2008.

23 Mar 2010

AOAC Research Institute validates MicroSEQ Salmonella spp. Detection Kit

Life Technologies Corporation today announced that its Applied Biosystems MicroSEQ® Salmonella spp. Detection Kit has been validated by the AOAC Research Institute for detection of the bacteria Salmonella.

23 Mar 2010

Walgreens's fiscal 2010 second-quarter sales up 3.1% to $17.0 billion

Walgreens today announced earnings and sales for the second quarter of fiscal year 2010.

23 Mar 2010

Merix Pharmaceutical introduces new Fast-Results! Genital Herpes Treatment

Merix Pharmaceutical Corp. unveiled its new Fast-Results!™ Genital Herpes Treatment March 1st while attending a retail industry trade show in Dallas. The first ever OTC treatment for genital herpes, Fast-Results! answers the unmet need of people who suffer painful symptoms caused by the herpes virus.

23 Mar 2010

Aureus Pharma to participate in € 118 million BioIntelligence R&D programme

Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today it’s participation in a EUR118.2 million (USD 160 million) project. The project is the Biointelligence R&D programme designed to promote the use of systemic modeling and simulation tools to exploit biomedical databases to improve research efficiency.

23 Mar 2010

TAP, AVISO GmbH announce second distribution agreement to supply CellCelector stem cell picker

The Automation Partnership, a world leader in the design and development of innovative automation for life science applications, today announced it has entered into a second distribution agreement with AVISO GmbH, a major German manufacturer of automation for the stem cell market.

23 Mar 2010

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

BioSante Pharmaceuticals, Inc. today announced positive GVAX AML Vaccine results and BioSante’s receipt of Orphan Drug designation from the FDA’s Office of Orphan Products Development for GVAX AML Vaccine in the treatment of acute myeloid leukemia. This Orphan Drug designation is the second GVAX cancer vaccine from BioSante to secure FDA orphan drug designation.

23 Mar 2010

CTSI licenses GeneGo's pathway analysis suite and database searching tool

GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that the Indiana Clinical and Translational Sciences Institute has licensed its pathway analysis suite MetaCore and its database searching tool Eureka.

23 Mar 2010

Medical News

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

Texas jury returns binding verdict of invalidity on two Covidien's patent claims covering trocar seal technology

ReGear Life Sciences achieves preferred partner status with Genesis Rehab Services

NMA to discuss impact of historic health care reform legislation on health disparities

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Visual collaboration makes its way into healthcare services

EMA validates InterMune's pirfenidone MAA for IPF

Breathing diesel exhaust during pregnancy linked with sluggishness in offspring

Alnylam Pharmaceuticals earns $20M technology transfer payment from Takeda Pharmaceutical

AOAC Research Institute validates MicroSEQ Salmonella spp. Detection Kit

Walgreens's fiscal 2010 second-quarter sales up 3.1% to $17.0 billion

Merix Pharmaceutical introduces new Fast-Results! Genital Herpes Treatment

Aureus Pharma to participate in € 118 million BioIntelligence R&D programme

TAP, AVISO GmbH announce second distribution agreement to supply CellCelector stem cell picker

BioSante Pharmaceuticals receives FDA Orphan Drug designation for GVAX AML Vaccine

CTSI licenses GeneGo's pathway analysis suite and database searching tool

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News